Rapid evaluation of the safety of COVID-19 vaccines: how well have we done?

Elizabeth Miller

doi:10.1016/j.cmi.2021.12.018

Rapid evaluation of the safety of COVID-19 vaccines: how well have we done?

Elizabeth Miller^*

^*Corresponding author for this work

Research output: Contribution to journal › Comment/debate

8 Citations (Scopus)

Original language	English
Pages (from-to)	477-478
Number of pages	2
Journal	Clinical Microbiology and Infection
Volume	28
Issue number	4
DOIs	https://doi.org/10.1016/j.cmi.2021.12.018
Publication status	Published - Apr 2022
Externally published	Yes

Bibliographical note

Funding Information:
Elizabeth Miller receives support from the National Institute for Health Research , Health Protection Research Unit in Immunisation , at the London School of Hygiene and Tropical Medicine in partnership with Public Health England (Grant Reference NIHR200929). The author declares no competing interests.

Keywords

Bells palsy and COVID-19 vaccine
COVID-19 vaccine safety
GBS and COVID-19 vaccine
Myocarditis and COVID-19 vaccine
Thrombosis and COVID-19 vaccine

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.cmi.2021.12.018

Cite this

@article{9bbde6f4d3204c92a17eba7ded82e91a,

title = "Rapid evaluation of the safety of COVID-19 vaccines: how well have we done?",

keywords = "Bells palsy and COVID-19 vaccine, COVID-19 vaccine safety, GBS and COVID-19 vaccine, Myocarditis and COVID-19 vaccine, Thrombosis and COVID-19 vaccine",

author = "Elizabeth Miller",

note = "Funding Information: Elizabeth Miller receives support from the National Institute for Health Research , Health Protection Research Unit in Immunisation , at the London School of Hygiene and Tropical Medicine in partnership with Public Health England (Grant Reference NIHR200929). The author declares no competing interests.",

year = "2022",

month = apr,

doi = "10.1016/j.cmi.2021.12.018",

language = "English",

volume = "28",

pages = "477--478",

journal = "Clinical Microbiology and Infection",

issn = "1198-743X",

publisher = "Elsevier B.V.",

number = "4",

}

TY - JOUR

T1 - Rapid evaluation of the safety of COVID-19 vaccines

T2 - how well have we done?

AU - Miller, Elizabeth

N1 - Funding Information: Elizabeth Miller receives support from the National Institute for Health Research , Health Protection Research Unit in Immunisation , at the London School of Hygiene and Tropical Medicine in partnership with Public Health England (Grant Reference NIHR200929). The author declares no competing interests.

PY - 2022/4

Y1 - 2022/4

KW - Bells palsy and COVID-19 vaccine

KW - COVID-19 vaccine safety

KW - GBS and COVID-19 vaccine

KW - Myocarditis and COVID-19 vaccine

KW - Thrombosis and COVID-19 vaccine

UR - http://www.scopus.com/inward/record.url?scp=85123095119&partnerID=8YFLogxK

U2 - 10.1016/j.cmi.2021.12.018

DO - 10.1016/j.cmi.2021.12.018

M3 - Comment/debate

AN - SCOPUS:85123095119

SN - 1198-743X

VL - 28

SP - 477

EP - 478

JO - Clinical Microbiology and Infection

JF - Clinical Microbiology and Infection

IS - 4

ER -

Rapid evaluation of the safety of COVID-19 vaccines: how well have we done?

Bibliographical note

Keywords

UN SDGs

Access to Document

Other files and links

Cite this